Replies to post #794012 on NorthWest Biotherapeutics Inc (NWBO)

[StonkMaster]

Hot dam. Good find.

[AllSheWrote]

Nice that they can talk to the Parliamentary Group but not shareholders.

[FeMike]

The review process is expected to conclude in the next couple of months

I don’t know who said this but the phrase “in the next couple of months” gives me serious PTSD when it comes to NWBO.

Their definition of “the next couple of months” is sometime 9-14 months from now.

Other than that, quite encouraging verbiage.

[dennisdave]

“The review process is expected to conclude in the next couple of months

this is really, really, really bad news and the answer as to why the stock was tanking so hard the last couple of days

https://braintumourresearch.org/pages/campaigning-appg-on-brain-tumours
Professor Ashkan will present on DCVax, a precision personalised immune
therapy for brain tumours. He will address the exceptionally comprehensive
review by the Medicines and Healthcare products Regulatory Agency
(MRHA) ahead of market authorisation that has been ongoing for over a year.
“The review process is expected to conclude in the next couple of months,
and the brain tumour community anxiously looks forward to the outcome given
the extremely poor patient prognosis and the lack of meaningful progress in the
field for the past 20 years.”

https://cdn.shopify.com/s/files/1/0615/3122/6285/files/BTR_APPG_OCT_25_BRIEFING_FINAL.pdf?v=1760531209

[skitahoe]

Thanks Lykiri,

A couple of months brings up the question of whether LP actually takes the Annual Meeting into next year, or holds it this year, perhaps even the 30th or 31st of December, which she did a couple of years ago. Of course, it's possible that if she schedules it late in the year with 30 days' notice, the approval could come before the meeting. Votes however should be scheduled in the notice to investors, she needs to make a very positive case for authorizing more shares if she can't speak about the status of the trial. Frankly, if she believes she has a financial path to not needing more shares for a few more months, I don't know that she doesn't take the meeting into next year after the approval.

The problem may not be that she has a positive story to tell but rather because of the delicate stage with the regulators, she cannot tell us at this time.

Gary

Gary

[skitahoe]

Thanks Lykiri,

A couple of months brings up the question of whether LP actually takes the Annual Meeting into next year, or holds it this year, perhaps even the 30th or 31st of December, which she did a couple of years ago. Of course, it's possible that if she schedules it late in the year with 30 days' notice, the approval could come before the meeting. Votes however should be scheduled in the notice to investors, she needs to make a very positive case for authorizing more shares if she can't speak about the status of the trial. Frankly, if she believes she has a financial path to not needing more shares for a few more months, I don't know that she doesn't take the meeting into next year after the approval.

The problem may not be that she has a positive story to tell but rather because of the delicate stage with the regulators, she cannot tell us at this time.

Gary